Modicus Prime

Modicus Prime develops an AI compliance platform designed for deploying auditable AI in manufacturing environments, with a specific focus on GxP-regulated industries such as pharmaceutical and biopharmaceutical production. The platform addresses both the compliance and technical requirements of AI and machine learning implementation, helping organizations manage AI lifecycles while meeting regulatory standards. The company's stated goal is to improve quality metrics and reduce commercial production costs through compliant AI deployment.

Modicus Prime serves life sciences organizations operating under GxP regulations, including pharmaceutical manufacturers and biopharmaceutical developers. The company's CEO has co-authored industry publications with ISPE's GAMP® program and BioPhorum, and the company participates in industry events such as BioProcess International, PDA conferences, and ISPE forums.

Core Platform Capabilities

• Life Cycle Oversight: Tools for managing the full lifecycle of AI and ML models within regulated manufacturing environments.
• Change Management: Functionality to track and manage changes to AI systems in a manner consistent with GxP compliance requirements.
• Regulatory Compliance: Features designed to support adherence to regulatory frameworks applicable to AI use in GxP settings.
• Optional AI Submodules: Additional modules available to extend the platform's capabilities depending on organizational needs.

Industry Engagement and Publications

• The CEO co-authored ISPE's GAMP® AI Guide for Pharma, a recognized industry reference for AI in regulated life sciences.
• The CEO also co-authored BioPhorum's AI Implementation publication, released in July 2025.
• Modicus Prime participates in and presents at industry conferences including BioProcess International (Boston, September 2025), PDA's Artificial Intelligence in Biopharmaceutical Development and Manufacturing conference, and ISPE Women in Biotech Frontiers.

Educational Resources

• Modicus Prime produces a webinar series in collaboration with ISPE GAMP® focused on AI and ML in regulated life sciences (GxP).
• The series covers topics including the concept phase and business need assessment, representative data sets, iterative model training and fine-tuning, computerized system integration and acceptance, and ongoing monitoring to maintain a state of control during operations.
• The webinar content is framed around real-world AI/ML applications in pharma, with case study examples intended to translate GAMP® principles into actionable practices supporting product quality, patient safety, and data integrity.

Modicus Prime operates as an early-stage company and is actively hiring, describing itself as a small team focused on improving pharmaceutical drug manufacturing quality through compliant AI and advanced analytics.